nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—CALM1—autonomic nervous system—attention deficit hyperactivity disorder	0.0671	0.161	CbGeAlD
Cinchocaine—SCN10A—forebrain—attention deficit hyperactivity disorder	0.0255	0.0613	CbGeAlD
Cinchocaine—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.0196	0.0471	CbGeAlD
Cinchocaine—Chloroprocaine—SLC6A3—attention deficit hyperactivity disorder	0.0163	0.414	CrCbGaD
Cinchocaine—CALM2—forebrain—attention deficit hyperactivity disorder	0.0157	0.0378	CbGeAlD
Cinchocaine—CALM1—forebrain—attention deficit hyperactivity disorder	0.0156	0.0376	CbGeAlD
Cinchocaine—SCN10A—nervous system—attention deficit hyperactivity disorder	0.0138	0.0333	CbGeAlD
Cinchocaine—Metoclopramide—DRD3—attention deficit hyperactivity disorder	0.0137	0.346	CrCbGaD
Cinchocaine—SCN10A—central nervous system—attention deficit hyperactivity disorder	0.0133	0.032	CbGeAlD
Cinchocaine—CALM2—cardiovascular system—attention deficit hyperactivity disorder	0.0133	0.032	CbGeAlD
Cinchocaine—CALM1—cardiovascular system—attention deficit hyperactivity disorder	0.0132	0.0318	CbGeAlD
Cinchocaine—CALM3—midbrain—attention deficit hyperactivity disorder	0.0132	0.0318	CbGeAlD
Cinchocaine—BCHE—forebrain—attention deficit hyperactivity disorder	0.0131	0.0315	CbGeAlD
Cinchocaine—SCN5A—nervous system—attention deficit hyperactivity disorder	0.0126	0.0302	CbGeAlD
Cinchocaine—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.0121	0.0291	CbGeAlD
Cinchocaine—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.0111	0.0266	CbGeAlD
Cinchocaine—SCN10A—brain—attention deficit hyperactivity disorder	0.0106	0.0254	CbGeAlD
Cinchocaine—CALM2—midbrain—attention deficit hyperactivity disorder	0.0104	0.025	CbGeAlD
Cinchocaine—CALM1—midbrain—attention deficit hyperactivity disorder	0.0103	0.0248	CbGeAlD
Cinchocaine—CALM3—cerebellum—attention deficit hyperactivity disorder	0.0102	0.0246	CbGeAlD
Cinchocaine—SCN5A—brain—attention deficit hyperactivity disorder	0.0096	0.0231	CbGeAlD
Cinchocaine—Metoclopramide—DRD2—attention deficit hyperactivity disorder	0.00945	0.24	CrCbGaD
Cinchocaine—BCHE—midbrain—attention deficit hyperactivity disorder	0.00865	0.0208	CbGeAlD
Cinchocaine—CALM2—nervous system—attention deficit hyperactivity disorder	0.00852	0.0205	CbGeAlD
Cinchocaine—CALM1—nervous system—attention deficit hyperactivity disorder	0.00849	0.0204	CbGeAlD
Cinchocaine—CALM3—brain—attention deficit hyperactivity disorder	0.0083	0.02	CbGeAlD
Cinchocaine—CALM2—central nervous system—attention deficit hyperactivity disorder	0.00821	0.0198	CbGeAlD
Cinchocaine—CALM1—central nervous system—attention deficit hyperactivity disorder	0.00817	0.0197	CbGeAlD
Cinchocaine—CALM2—cerebellum—attention deficit hyperactivity disorder	0.00802	0.0193	CbGeAlD
Cinchocaine—CALM1—cerebellum—attention deficit hyperactivity disorder	0.00798	0.0192	CbGeAlD
Cinchocaine—BCHE—nervous system—attention deficit hyperactivity disorder	0.00711	0.0171	CbGeAlD
Cinchocaine—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00684	0.0165	CbGeAlD
Cinchocaine—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00669	0.0161	CbGeAlD
Cinchocaine—CALM2—brain—attention deficit hyperactivity disorder	0.00652	0.0157	CbGeAlD
Cinchocaine—CALM1—brain—attention deficit hyperactivity disorder	0.00649	0.0156	CbGeAlD
Cinchocaine—BCHE—brain—attention deficit hyperactivity disorder	0.00543	0.0131	CbGeAlD
Cinchocaine—SCN10A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00288	0.00528	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00287	0.00527	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00283	0.0052	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00282	0.00518	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00272	0.00499	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00263	0.00483	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00263	0.00483	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00263	0.00483	CbGpPWpGaD
Cinchocaine—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00259	0.00476	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00249	0.00458	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00243	0.00446	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00243	0.00445	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.00432	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00235	0.00432	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00226	0.00414	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00216	0.00397	CbGpPWpGaD
Cinchocaine—CALM3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.0021	0.00386	CbGpPWpGaD
Cinchocaine—CALM3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00208	0.00382	CbGpPWpGaD
Cinchocaine—CALM1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00204	0.00373	CbGpPWpGaD
Cinchocaine—CALM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00204	0.00373	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00202	0.00371	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00201	0.00369	CbGpPWpGaD
Cinchocaine—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00201	0.00369	CbGpPWpGaD
Cinchocaine—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00201	0.00369	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.0019	0.00349	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00186	0.00341	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00185	0.00339	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00184	0.00337	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00184	0.00337	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00182	0.00334	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00176	0.00323	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00176	0.00323	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00173	0.00317	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00171	0.00314	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0017	0.00312	CbGpPWpGaD
Cinchocaine—CALM3—IFN-gamma pathway—EP300—attention deficit hyperactivity disorder	0.00162	0.00296	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00156	0.00287	CbGpPWpGaD
Cinchocaine—CALM2—IFN-gamma pathway—EP300—attention deficit hyperactivity disorder	0.00156	0.00287	CbGpPWpGaD
Cinchocaine—CALM1—IFN-gamma pathway—EP300—attention deficit hyperactivity disorder	0.00156	0.00287	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00154	0.00283	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00151	0.00277	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00151	0.00277	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00145	0.00267	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00141	0.00258	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00141	0.00258	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00139	0.00256	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00136	0.00249	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00135	0.00247	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00135	0.00247	CbGpPWpGaD
Cinchocaine—CALM3—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.00135	0.00247	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00132	0.00242	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00131	0.00241	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00131	0.00241	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00131	0.0024	CbGpPWpGaD
Cinchocaine—CALM2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.0013	0.00239	CbGpPWpGaD
Cinchocaine—CALM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.0013	0.00239	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.0013	0.00239	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.0013	0.00238	CbGpPWpGaD
Cinchocaine—CALM3—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.00234	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00126	0.00231	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00125	0.0023	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00125	0.0023	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00125	0.0023	CbGpPWpGaD
Cinchocaine—CALM2—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.00227	CbGpPWpGaD
Cinchocaine—CALM1—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.00227	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00122	0.00224	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00122	0.00224	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00121	0.00222	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00121	0.00222	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0012	0.0022	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00116	0.00213	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00116	0.00213	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00111	0.00204	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.0011	0.00202	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00109	0.00201	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00108	0.00198	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00108	0.00198	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00107	0.00197	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00107	0.00195	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00107	0.00195	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00106	0.00194	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00106	0.00194	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00104	0.0019	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00104	0.0019	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000995	0.00183	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000993	0.00182	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000963	0.00177	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000963	0.00177	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00096	0.00176	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00096	0.00176	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000844	0.00155	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000838	0.00154	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000816	0.0015	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000816	0.0015	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000811	0.00149	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000811	0.00149	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00079	0.00145	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000789	0.00145	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—STUB1—attention deficit hyperactivity disorder	0.000765	0.0014	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000764	0.0014	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000764	0.0014	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000747	0.00137	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—STUB1—attention deficit hyperactivity disorder	0.00074	0.00136	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—STUB1—attention deficit hyperactivity disorder	0.00074	0.00136	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000719	0.00132	CbGpPWpGaD
Cinchocaine—CALM3—Disease—STUB1—attention deficit hyperactivity disorder	0.000706	0.0013	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000705	0.00129	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000696	0.00128	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000696	0.00128	CbGpPWpGaD
Cinchocaine—CALM2—Disease—STUB1—attention deficit hyperactivity disorder	0.000683	0.00125	CbGpPWpGaD
Cinchocaine—CALM1—Disease—STUB1—attention deficit hyperactivity disorder	0.000683	0.00125	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000682	0.00125	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000682	0.00125	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000658	0.00121	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000637	0.00117	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000637	0.00117	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000634	0.00116	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000613	0.00112	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000613	0.00112	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00058	0.00106	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000561	0.00103	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000561	0.00103	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000545	0.001	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000545	0.001	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000536	0.000983	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000525	0.000964	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000508	0.000932	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000498	0.000914	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000495	0.000907	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000492	0.000902	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000492	0.000902	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000488	0.000896	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000478	0.000878	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000478	0.000878	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000473	0.000867	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000473	0.000867	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000436	0.000799	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000427	0.000783	CbGpPWpGaD
Cinchocaine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000427	0.000783	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000425	0.00078	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000416	0.000764	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000415	0.000761	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000413	0.000758	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000413	0.000758	CbGpPWpGaD
Cinchocaine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000413	0.000758	CbGpPWpGaD
Cinchocaine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	0.000413	0.000758	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000411	0.000754	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000411	0.000754	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000408	0.000749	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000403	0.000739	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000403	0.000739	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000397	0.000728	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000396	0.000727	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000395	0.000725	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000395	0.000725	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000384	0.000705	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000384	0.000704	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000384	0.000704	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000383	0.000703	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.000383	0.000703	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000378	0.000693	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000373	0.000685	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000372	0.000682	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000372	0.000682	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000366	0.000671	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000366	0.000671	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000361	0.000662	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000361	0.000662	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000351	0.000644	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000351	0.000644	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000348	0.000638	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000345	0.000633	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000339	0.000623	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000339	0.000623	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000339	0.000623	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000339	0.000623	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000336	0.000617	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000336	0.000617	CbGpPWpGaD
Cinchocaine—CALM3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000335	0.000614	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000334	0.000612	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000334	0.000612	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.00033	0.000606	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000328	0.000601	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000327	0.0006	CbGpPWpGaD
Cinchocaine—CALM2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000324	0.000594	CbGpPWpGaD
Cinchocaine—CALM1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000324	0.000594	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000321	0.000589	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000318	0.000583	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000316	0.00058	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000316	0.00058	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00031	0.000569	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00031	0.000569	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000289	0.000529	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00028	0.000514	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000279	0.000512	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000279	0.000512	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000271	0.000498	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000271	0.000498	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000267	0.00049	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000474	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000474	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000252	0.000463	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000244	0.000448	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000244	0.000448	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000243	0.000447	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000236	0.000432	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000236	0.000432	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000234	0.00043	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000227	0.000417	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000227	0.000416	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000227	0.000416	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000225	0.000412	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000223	0.00041	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00022	0.000404	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00022	0.000403	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00022	0.000403	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000217	0.000399	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000217	0.000399	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.000396	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.000396	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000213	0.000391	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000213	0.000391	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000213	0.00039	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000211	0.000387	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000206	0.000377	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000206	0.000377	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000205	0.000377	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000204	0.000375	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000204	0.000375	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000202	0.000371	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000199	0.000364	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000199	0.000364	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000196	0.000359	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000196	0.000359	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000144	0.000264	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000142	0.00026	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000139	0.000255	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000139	0.000255	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—EP300—attention deficit hyperactivity disorder	0.000118	0.000216	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—EP300—attention deficit hyperactivity disorder	0.000114	0.000209	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—EP300—attention deficit hyperactivity disorder	0.000114	0.000209	CbGpPWpGaD
Cinchocaine—CALM3—Disease—EP300—attention deficit hyperactivity disorder	0.000109	0.0002	CbGpPWpGaD
Cinchocaine—CALM2—Disease—EP300—attention deficit hyperactivity disorder	0.000105	0.000193	CbGpPWpGaD
Cinchocaine—CALM1—Disease—EP300—attention deficit hyperactivity disorder	0.000105	0.000193	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—EP300—attention deficit hyperactivity disorder	9.11e-05	0.000167	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—EP300—attention deficit hyperactivity disorder	8.82e-05	0.000162	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—EP300—attention deficit hyperactivity disorder	8.82e-05	0.000162	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.62e-05	0.00014	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.37e-05	0.000135	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.37e-05	0.000135	CbGpPWpGaD
